Structure-activity studies of CTL inhibitory peptides derived from HLA Class I molecules
โ Scribed by Erich J Schwartz; Jodi Goldberg; Carol Clayberger; Alan M Krensky; John H Griffin
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 281 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
โฆ Synopsis
A series of dimeric peptides derived from a conserved HLA Class I hexapeptide sequence have been synthesized and tested for their ability to inhibit T cell-mediated lysis and to disrupt membranes. Structureactivity studies of the C-N/N-C dimer show that activity is especially sensitive to substitution of isoleucine residues. The results further define and delimit the basis for activity by HLA-derived peptides.
๐ SIMILAR VOLUMES
## Abstract Bitterness represents a major challenge in industrial application of food protein hydrolysates or bioactive peptides and is a major factor that controls the flavor of formulated therapeutic products. The aim of this work was to apply quantitative structureโactivity relationship modeling
Chronic myeloid leukemia (CML) is characterized cytogenetically by a t(9;22) translocation which generates a hybrid bcr-abl gene, encoding a p210(bcr-abl) fusion protein. The induction in vitro of leukemia-specific T cells reactive with p210(bcr-abl) is a strategy developed for an immunological ther
## Abstract Eighteen coumarin derivatives were tested as inhibitors of oxidosqualene cyclases (OSCs) from __Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii, Homo sapiens__, and __Arabidopsis thaliana__, all expressed in an OSCโdefective strain of __S.โ cerevisiae__.35 All the compo